NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 110.95 Million JPY | -30.48% |
| 2022 | 159.59 Million JPY | -28.35% |
| 2021 | 222.74 Million JPY | -18.97% |
| 2020 | 274.89 Million JPY | -42.13% |
| 2019 | 475.01 Million JPY | 13.95% |
| 2018 | 416.85 Million JPY | 117.99% |
| 2017 | 191.22 Million JPY | 21.29% |
| 2016 | 157.66 Million JPY | -25.53% |
| 2015 | 211.72 Million JPY | -54.37% |
| 2014 | 463.96 Million JPY | 60.01% |
| 2013 | 289.95 Million JPY | 187.25% |
| 2012 | 100.94 Million JPY | -54.39% |
| 2011 | 221.32 Million JPY | 566.41% |
| 2010 | 33.21 Million JPY | -29.17% |
| 2009 | 46.89 Million JPY | -55.91% |
| 2008 | 106.34 Million JPY | -45.3% |
| 2007 | 194.39 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - JPY | -100.0% |
| 2023 Q3 | 11.79 Million JPY | -51.3% |
| 2023 Q4 | 23.97 Million JPY | 103.34% |
| 2023 Q1 | 50.98 Million JPY | 11.74% |
| 2023 Q2 | 24.21 Million JPY | -52.51% |
| 2023 FY | 110.95 Million JPY | -30.48% |
| 2022 Q1 | 17.74 Million JPY | -67.34% |
| 2022 Q4 | 45.62 Million JPY | 10.53% |
| 2022 FY | 159.59 Million JPY | -28.35% |
| 2022 Q2 | 54.95 Million JPY | 209.73% |
| 2022 Q3 | 41.27 Million JPY | -24.88% |
| 2021 Q3 | 57.15 Million JPY | 16.88% |
| 2021 Q4 | 54.32 Million JPY | -4.95% |
| 2021 Q2 | 48.89 Million JPY | -21.59% |
| 2021 Q1 | 62.36 Million JPY | 11.38% |
| 2021 FY | 222.74 Million JPY | -18.97% |
| 2020 FY | 274.89 Million JPY | -42.13% |
| 2020 Q2 | 51.06 Million JPY | -57.55% |
| 2020 Q3 | 47.53 Million JPY | -6.92% |
| 2020 Q4 | 55.99 Million JPY | 17.8% |
| 2020 Q1 | 120.3 Million JPY | 6.68% |
| 2019 Q1 | 125.49 Million JPY | -10.75% |
| 2019 Q4 | 112.77 Million JPY | -8.44% |
| 2019 FY | 475.01 Million JPY | 13.95% |
| 2019 Q2 | 113.57 Million JPY | -9.5% |
| 2019 Q3 | 123.17 Million JPY | 8.45% |
| 2018 FY | 416.85 Million JPY | 117.99% |
| 2018 Q4 | 140.6 Million JPY | 41.8% |
| 2018 Q3 | 99.15 Million JPY | -35.94% |
| 2018 Q1 | 22.31 Million JPY | -75.96% |
| 2018 Q2 | 154.77 Million JPY | 593.61% |
| 2017 Q3 | 49.59 Million JPY | 89.9% |
| 2017 Q1 | 22.69 Million JPY | -64.53% |
| 2017 FY | 191.22 Million JPY | 21.29% |
| 2017 Q4 | 92.81 Million JPY | 87.14% |
| 2017 Q2 | 26.11 Million JPY | 15.07% |
| 2016 Q2 | 31.41 Million JPY | 33.35% |
| 2016 Q1 | 23.56 Million JPY | -82.93% |
| 2016 Q4 | 63.99 Million JPY | 65.38% |
| 2016 Q3 | 38.69 Million JPY | 23.15% |
| 2016 FY | 157.66 Million JPY | -25.53% |
| 2015 Q3 | 69.15 Million JPY | 6679.71% |
| 2015 Q1 | 3.49 Million JPY | -98.61% |
| 2015 Q4 | 138.05 Million JPY | 99.64% |
| 2015 Q2 | 1.02 Million JPY | -70.79% |
| 2015 FY | 211.72 Million JPY | -54.37% |
| 2014 Q1 | 26.98 Million JPY | 98.73% |
| 2014 FY | 463.96 Million JPY | 60.01% |
| 2014 Q4 | 250.82 Million JPY | 2655.69% |
| 2014 Q3 | 9.1 Million JPY | -94.86% |
| 2014 Q2 | 177.05 Million JPY | 556.11% |
| 2013 FY | 289.95 Million JPY | 187.25% |
| 2013 Q2 | 125.44 Million JPY | 28.26% |
| 2013 Q3 | 53.13 Million JPY | -57.64% |
| 2013 Q4 | 13.57 Million JPY | -74.44% |
| 2013 Q1 | 97.8 Million JPY | 251.94% |
| 2012 FY | 100.94 Million JPY | -54.39% |
| 2012 Q3 | 62.4 Million JPY | 54.18% |
| 2012 Q2 | 40.47 Million JPY | 236.16% |
| 2012 Q4 | 27.79 Million JPY | -55.47% |
| 2012 Q1 | -29.72 Million JPY | -136.83% |
| 2011 Q4 | 80.72 Million JPY | 272.12% |
| 2011 Q1 | -5.82 Million JPY | -165.57% |
| 2011 FY | 221.32 Million JPY | 566.41% |
| 2011 Q3 | -46.89 Million JPY | -124.26% |
| 2011 Q2 | 193.31 Million JPY | 3421.06% |
| 2010 Q1 | -2.9 Million JPY | 33.66% |
| 2010 Q4 | 8.87 Million JPY | -65.84% |
| 2010 Q3 | 25.99 Million JPY | 1974.22% |
| 2010 Q2 | 1.25 Million JPY | 143.07% |
| 2010 FY | 33.21 Million JPY | -29.17% |
| 2009 Q2 | 12.05 Million JPY | 275.32% |
| 2009 Q3 | 46.09 Million JPY | 282.31% |
| 2009 FY | 46.89 Million JPY | -55.91% |
| 2009 Q4 | -4.38 Million JPY | -109.51% |
| 2009 Q1 | -6.87 Million JPY | -125.42% |
| 2008 Q3 | -30.49 Million JPY | 0.0% |
| 2008 Q4 | 27.05 Million JPY | 188.72% |
| 2008 FY | 106.34 Million JPY | -45.3% |
| 2007 FY | 194.39 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 94.102% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -38.167% |
| GNI Group Ltd. | 22.43 Billion JPY | 99.505% |
| Linical Co., Ltd. | 3.77 Billion JPY | 97.063% |
| Trans Genic Inc. | 2.24 Billion JPY | 95.067% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -12.93% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 95.53% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 91.416% |
| AnGes, Inc. | -3.06 Billion JPY | 103.62% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 162.434% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 98.852% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 78.551% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 92.351% |
| CanBas Co., Ltd. | -984 Million JPY | 111.276% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 71.673% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 93.3% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 72.163% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 89.325% |
| PeptiDream Inc. | 17.21 Billion JPY | 99.356% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -262.542% |
| Ribomic Inc. | -10.5 Million JPY | 1156.523% |
| SanBio Company Limited | -14.5 Million JPY | 865.003% |
| Healios K.K. | 108 Million JPY | -2.737% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 32638.416% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 287.915% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 7438.36% |
| StemRIM | -44.34 Million JPY | 350.188% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 96.516% |
| FunPep Company Limited | -680.28 Million JPY | 116.31% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -60.225% |
| Stella Pharma Corporation | 217.29 Million JPY | 48.938% |
| TMS Co., Ltd. | -6.95 Million JPY | 1696.489% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 64.727% |
| Cuorips Inc. | 9.63 Million JPY | -1052.071% |
| K Pharma,Inc. | 910 Million JPY | 87.807% |
| Takara Bio Inc. | 25.45 Billion JPY | 99.564% |
| ReproCELL Incorporated | 1.1 Billion JPY | 89.956% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 90.715% |
| StemCell Institute Inc. | 1.57 Billion JPY | 92.959% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 93.343% |
| CellSeed Inc. | 107.15 Million JPY | -3.547% |